Exosomes as Biomarkers to Monitor Disease Progression and Response to Therapy in Ewing sarcoma |
Children's Mercy / Glenson Samuel, MD |
Young Investigator Grants |
2014 |
Missouri |
Targeted Therapy for Core Binding Factor Leukemia |
University of Massachusetts Medical School / John Pulikkan, PhD |
Young Investigator Grants |
2014 |
Massachusetts |
Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy |
Dana-Farber Cancer Institute / Yana Pikman, MD |
Young Investigator Grants |
2014 |
Massachusetts |
Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia |
National Cancer Institute / Christopher Chien, PhD |
Young Investigator Grants |
2014 |
Maryland |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children's Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells |
Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD |
Young Investigator Grants |
2014 |
Washington |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
Molecular Mechanism and Development of Therapeutic Strategies Targeting MYCN-induced Calcium Signaling in Advanced Neuroblastoma |
University of Hawaii at Hilo / Ingo Koomoa-Lange, PhD |
Young Investigator Grants |
2014 |
Hawaii |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan / Carl Koschmann, MD |
Young Investigator Grants |
2014 |
Michigan |